Tempus ECG-AF vs Aorta-CAD
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, Tempus ECG-AF, focuses on predicting the risk of future atrial fibrillation using 12-lead ECGs in patients aged 65 or older. In contrast, Tool B, Aorta-CAD, assists physicians in detecting existing aortic atherosclerosis and ectasia from chest X-rays. While both are FDA-cleared cardiology AI tools, their distinct input modalities (ECG vs. X-ray) and specific clinical targets (arrhythmia risk vs. structural disease detection) make them complementary rather than direct competitors.
Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your primary goal is to proactively identify older patients (65+) at increased risk of developing new-onset atrial fibrillation within the next year, utilizing their standard 12-lead ECGs. This tool is ideal for integrating into cardiology or geriatrics workflows to support earlier intervention and follow-up for high-risk individuals without pre-existing AF or related cardiac devices.
View Tempus ECG-AF →Choose Aorta-CAD if…
Choose Aorta-CAD if you need to enhance the detection of aortic atherosclerosis and ectasia during the interpretation of routine chest X-rays. This cloud-based AI solution is best suited for radiology and internal medicine practices looking to improve diagnostic accuracy for these specific aortic conditions by providing an intelligent overlay on existing X-ray images, seamlessly integrating into current workflows.
View Aorta-CAD →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-AF | Aorta-CAD |
|---|---|---|
| Pricing | Contact vendor | Unknown |
| Deployment | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. | Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-AF | Aorta-CAD |
|---|---|---|
| Name | Tempus ECG-AF | Aorta-CAD |
| Company | Tempus AI, Inc. | Imagen Technologies |
| Description | FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. | FDA-cleared, cloud-based AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays, integrating seamlessly into existing workflows. |
| Target Condition | Atrial Fibrillation/Flutter (AF) within 12 months | Aortic Atherosclerosis and Aortic Ectasia |
| Input Data | 12-lead ECG recordings | Chest X-rays |
| Target Patient Population | Patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery | Not specified |
| Key Features | AI-based algorithm for 12-lead ECG analysis; Detects signs associated with new onset Atrial Fibrillation (AF) within 12 months; Intended for patients 65 years or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery; Results interpreted in conjunction with other diagnostic information and clinical history; Compatible with FDA authorized resting 12-lead ECGs from GE Medical Systems and Philips Medical Systems; Trained on over 1.5 million ECGs from over 500,000 patients. | Detects and highlights radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia; Cloud-based, software-only medical device; Utilizes deep learning algorithms for analysis; Seamlessly integrates into existing X-ray reading workflows; Creates annotations via an overlay that can be toggled on/off; Assists physicians (radiologists and PCPs) in interpreting chest X-rays; Demonstrated 62% relative reduction in misses for aortic calcification in clinical study; Demonstrated 35% relative reduction in misses for dilated aorta in clinical study. |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-AF and Aorta-CAD.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Tempus ECG-AF is an AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months. Aorta-CAD by Imagen Technologies is an AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays.
Tempus ECG-AF analyzes 12-lead ECG recordings. Aorta-CAD analyzes chest X-rays.
Tempus ECG-AF is intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery. Aorta-CAD assists physicians, including radiologists and PCPs, in interpreting chest X-rays for aortic conditions, with no specific age or exclusion criteria mentioned in the provided facts.
Yes, CMS reimbursement is available for Tempus ECG-AF with CPT codes 0764T and 0765T, assigned to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025. For Aorta-CAD, pricing details require direct contact with Imagen Technologies.
Tempus ECG-AF supports earlier identification and follow-up for patients at increased risk of developing AF within 12 months. Aorta-CAD demonstrated a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta in a clinical study.
Tempus ECG-AF is designed for Cardiology, Geriatrics, and Internal Medicine. Aorta-CAD is designed for Cardiology, Internal Medicine, and Radiology.